Skip to content
OpenCapital
Get started

Charles River Laboratories CRL Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$1.0BBeat by $17.7MDiluted EPS$2.43Beat by $0.11
Revenue estimate$987.2M
EPS estimate$2.32

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$976.1M
EPS estimate$2.72

Financials

Q3 2025

Income statement

See full
Revenue$1.0B-0.5%
Operating income$133.8M+14.0%
Net income$54.4M-21.9%
EPS (diluted)$1.10-17.3%

Balance sheet

See full
Cash & equivalents$209.2M-1.1%
Total debt$2.7B-4.8%
Total equity$3.4B-10.0%
Total assets$7.5B-6.1%

Cash flow

See full
Operating cash flow$213.8M-15.1%
CapEx$35.6M-8.1%
Free cash flow$178.2M-16.3%

Valuation & ratios

Valuation

as of 09/27/25
See full
Market cap$7.7B-24.3%
Enterprise value$10.15B-20.4%
P/S1.9×-0.6×

Profitability

See full
FCF margin13.5%-0.3pp

Returns & leverage

See full
Debt / equity0.8×0.0×
Current ratio1.4×-0.1×

Segments

By segment

See full
DSA$600.7M-2.3%
RMS$213.5M+7.9%
Manufacturing$190.7M-3.1%

By geography

See full
Europe$277.7M+4.0%
Asia Pacific$51.7M+14.8%
Other$21.1M+87.1%

By product

See full
Cost of services provided (excluding amortization of intangible assets)$808.0M-2.9%

Versus estimates

Revenue

Q1 2026$995.8MBeat by $18.4MQ4 2025$994.2MBeat by $7.2M
Q3 2025$1.0BBeat by $17.7M
Q2 2025$1.0BBeat by $63.2MQ1 2025$984.2MBeat by $25.4MQ4 2024$1.0BBeat by $54.3M

Diluted EPS

Q1 2026$2.06Beat by $0.10Q4 2025$2.39Beat by $0.06
Q3 2025$2.43Beat by $0.11
Q2 2025$3.12Beat by $0.62Q1 2025$2.34Beat by $0.28Q4 2024$2.66Beat by $0.16

Ask the moment Charles River Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Charles River Laboratories report Q3 2025 earnings?
Charles River Laboratories (CRL) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Charles River Laboratories's Q3 2025 revenue and EPS?
Charles River Laboratories reported revenue of $1.0B and diluted EPS of $2.43 for Q3 2025.
Did Charles River Laboratories beat estimates in Q3 2025?
Revenue beat the consensus estimate of $987.2M by $17.7M. EPS beat the consensus estimate of $2.32 by $0.11.
How did Charles River Laboratories's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.5% from $1.0B a year earlier and diluted EPS declined 6.2% from $2.59.
Where can I find Charles River Laboratories's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001100682-25-000041) and the 10-Q periodic report (0001100682-25-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.